We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in ... Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment. Show more
Danaher Schedules First Quarter 2024 Earnings Conference Call PR Newswire WASHINGTON, March 21, 2024 WASHINGTON, March 21, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it...
Danaher to Present at TD Cowen Health Care Conference PR Newswire WASHINGTON, Feb. 27, 2024 WASHINGTON, Feb. 27, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and...
Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets PR Newswire WASHINGTON, Feb. 22, 2024 WASHINGTON, Feb. 22, 2024 /PRNewswire/ -- Danaher Corporation (NYSE:...
Danaher Announces Quarterly Dividend PR Newswire WASHINGTON, Feb. 21, 2024 WASHINGTON, Feb. 21, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors...
Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development PR Newswire WASHINGTON, Feb. 5, 2024 Danaher Beacon...
Danaher Reports Fourth Quarter and Full Year 2023 Results PR Newswire WASHINGTON, Jan. 30, 2024 WASHINGTON, Jan. 30, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today...
Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution PR...
By Will Feuer Danaher said a key revenue figure will fall in the fourth quarter, but by less than the industrial heavyweight had previously forecast. The company said adjusted core revenue is...
Danaher CEO to Comment on Financial Performance PR Newswire WASHINGTON, Jan. 8, 2024 WASHINGTON, Jan. 8, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced that its...
Danaher to Present at J.P. Morgan Healthcare Conference PR Newswire WASHINGTON, Jan. 2, 2024 WASHINGTON, Jan. 2, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -9.08 | -3.69947848761 | 245.44 | 246.98 | 230.74 | 2721090 | 240.47307898 | CS |
4 | -15.9 | -6.30302069294 | 252.26 | 256.51 | 230.74 | 2447860 | 245.53630878 | CS |
12 | 6.16 | 2.67593397046 | 230.2 | 259 | 226.62 | 2663268 | 246.9505632 | CS |
26 | 25.48 | 12.0827010622 | 210.88 | 259 | 182.09 | 2864857 | 228.66091929 | CS |
52 | -23.52 | -9.05033092196 | 259.88 | 269.61 | 182.09 | 2962272 | 234.79547133 | CS |
156 | -5.48 | -2.26596096593 | 241.84 | 333.96 | 182.09 | 2660957 | 260.09008021 | CS |
260 | 108.12 | 84.3106674984 | 128.24 | 333.96 | 119.6 | 3076144 | 215.11067544 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions